CIM
AGN

Calvert Investment Management’s Allergan Inc AGN Stock Holding History

Calvert Investment Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-11,793
Closed -$2.51M – 631
2014
Q4 		$2.51M Buy
11,793
+962
+9% +$191K 0.17% 140
2014
Q3 		$1.93M Buy
10,831
+7,999
+282% +$1.33M 0.14% 156
2014
Q2 		$479K Hold
2,832
– – 0.03% 246
2014
Q1 		$351K Sell
2,832
-21
-0.7% -$2.56K 0.02% 270
2013
Q4 		$317K Hold
2,853
– – 0.02% 275
2013
Q3 		$258K Sell
2,853
-219
-7% -$19.7K 0.03% 277
2013
Q2 		$259K Buy
+3,072
New +$319K 0.04% 263

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Calvert Investment Management's AGN Position: Q1 2015 in Review

Calvert Investment Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 11,793 shares — an estimated $2.51M sold.

Calvert Investment Management first reported a position in AGN in Q2 2013 and held it in 7 quarters. The position peaked at $2.51M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Calvert Investment Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Calvert Investment Management sold 11,793 Allergan Inc shares in Q1 2015, an estimated $2.51M.
  • Calvert Investment Management first reported a position in Allergan Inc in Q2 2013 and held it in 7 quarters.
  • Calvert Investment Management's Allergan Inc position peaked at $2.51M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Calvert Investment Management's 13F filing for Q1 2015, filed 13 Apr 2015.